| CAS Number | 171440-18-9 |
| Catalog Number | AG00AD5F(AGN-PC-0Q9XH3) |
| Chemical Name | (R)-(+)-Rabeprazole sodium |
| IUPAC Name | sodium;2-[(R)-[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]benzimidazol-1-ide |
| InChI | InChI=1S/C18H20N3O3S.Na/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18;/h3-4,6-9H,5,10-12H2,1-2H3;/q-1;+1/t25-;/m1./s1 |
| InChI Key | KRCQSTCYZUOBHN-VQIWEWKSSA-N |
| MDL Number | MFCD11840547 |
| Molecular Formula | C18H20N3NaO3S |
| Molecular Weight | 381.4245 |
| SMILES | O=[S@@](C1=NC2=CC=CC=C2[N-]1)CC3=NC=CC(OCCCOC)=C3C.[Na+] |
| Synonyms | Dexrabeprazole sodium,
171440-18-9,
(R)-Rabeprazole Sodium Salt,
KS-00000RXJ,
AKOS015994685,
KS-1101,
AK322278,
FT-0689461,
J-010725,
UNII-3L36P16U4R component KRCQSTCYZUOBHN-VQIWEWKSSA-N,
sodium (R)-2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide,
RABEPRAZOLE SODIUM,
ACN-038188,
CID10786084,
A16147,
117976-90-6,
|
| Complexity | 446 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 2 |
| Defined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 381.112g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 26 |
| Hydrogen Bond Acceptor Count | 7 |
| Hydrogen Bond Donor Count | 0 |
| Isotope Atom Count | 0 |
| Molecular Weight | 381.426g/mol |
| Monoisotopic Mass | 381.112g/mol |
| Rotatable Bond Count | 8 |
| Topological Polar Surface Area | 81.5A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
GHS Hazard and Precautionary Statements
| Symbol: |  |
|
Hazard Class
|
|
|
Hazard statements
|
H302-H315-H319-H335
|
|
Packing Group
|
|
|
Precautionary statements
|
P261-P305+P351+P338
|
|
UN Code
|
|
Certificate of Analysis
Lot Number